Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37178894)

  • 1. pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer.
    Tian Z; Wu X; Peng L; Yu N; Gou G; Zuo W; Yang J
    Int J Biol Macromol; 2023 Jul; 242(Pt 2):124819. PubMed ID: 37178894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides.
    Tian Z; Zhao Y; Mai Y; Qiao F; Guo J; Dong L; Niu Y; Gou G; Yang J
    Int J Pharm; 2022 Mar; 616():121522. PubMed ID: 35093460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.
    Zhang Y; Zhu W; Zhang H; Han J; Zhang L; Lin Q; Ai F
    Int J Pharm; 2017 Oct; 532(1):384-392. PubMed ID: 28903067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.
    Qiao F; Jiang Z; Fang W; Sun J; Hu Q
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
    Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pH-responsive quaternary ammonium chitosan-liposome nanoparticles for periodontal treatment.
    Hu F; Zhou Z; Xu Q; Fan C; Wang L; Ren H; Xu S; Ji Q; Chen X
    Int J Biol Macromol; 2019 May; 129():1113-1119. PubMed ID: 30218737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
    Verma A; Sharma S; Gupta PK; Singh A; Teja BV; Dwivedi P; Gupta GK; Trivedi R; Mishra PR
    Acta Biomater; 2016 Feb; 31():288-300. PubMed ID: 26685755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silver nanoparticles functionalized Paclitaxel nanocrystals enhance overall anti-cancer effect on human cancer cells.
    Muhammad N; Zhao H; Song W; Gu M; Li Q; Liu Y; Li C; Wang J; Zhan H
    Nanotechnology; 2021 Feb; 32(8):085105. PubMed ID: 33197899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP/Hyals dually responsive core-shell hyaluronan/chitosan-based drug nanocarrier for potential application in breast cancer therapy.
    Li H; Zhuang S; Yang Y; Zhou F; Rong J; Zhao J
    Int J Biol Macromol; 2021 Jul; 183():839-851. PubMed ID: 33965490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon.
    Li P; Yang Z; Wang Y; Peng Z; Li S; Kong L; Wang Q
    J Microencapsul; 2015; 32(1):40-5. PubMed ID: 25198909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
    Samprasit W; Opanasopit P; Chamsai B
    Pharm Dev Technol; 2021 Mar; 26(3):362-372. PubMed ID: 33423571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation.
    Sinha P; Udhumansha U; Rathnam G; Ganesh M; Jang HT
    Int J Biol Macromol; 2018 Oct; 117():840-850. PubMed ID: 29807085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer.
    Zhao C; Cao W; Zheng H; Xiao Z; Hu J; Yang L; Chen M; Liang G; Zheng S; Zhao C
    Int J Nanomedicine; 2019; 14():1597-1618. PubMed ID: 30880968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization of cross-linked quaternary chitosan salt and its adsorption of perchlorate from water].
    Xie YH; Li SY; Liu GL
    Huan Jing Ke Xue; 2011 Sep; 32(9):2537-42. PubMed ID: 22165217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
    Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
    Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.